EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements

被引：1
作者：
Nam, Mann Hua [1 ]
Hsieh, Yao-Yu [2 ,3 ]
Chen, Bo-Jung [1 ]
机构：
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, New Taipei, Taiwan
[2] Taipei Med Univ, Shuang Ho Hosp, Div Hematol & Oncol, New Taipei, Taiwan
[3] Taipei Med Univ, Sch Med, Div Hematol & Oncol, Dept Internal Med, Taipei, Taiwan
来源：
PATHOLOGY | 2022年 / 54卷 / 05期
关键词：
EPSTEIN-BARR-VIRUS;
D O I：
10.1016/j.pathol.2021.09.009
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：634 / 636
页数：4
相关论文
共 50 条
  • [21] Clinical features and survival impact of EBV-positive diffuse large B-cell lymphoma with different age cutoffs
    Nan, F-F
    Zhang, L.
    Li, L.
    Li, X.
    Sun, Z-C
    Zhang, X-D
    Li, Z-M
    Li, S-C
    Xiao, S.
    Shang, Y-F
    Zhang, M-Z
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (17) : 8947 - 8956
  • [22] In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly
    Stuhlmann-Laeisz, Christiane
    Borchert, Alisa
    Quintanilla-Martinez, Leticia
    Hoeller, Sylvia
    Tzankov, Alexandar
    Oschlies, Ilske
    Kreuz, Markus
    Trappe, Ralf
    Klapper, Wolfram
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 39 - 44
  • [23] Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma
    Lap, Coen J.
    Nassereddine, Samah
    Dunleavy, Kieron
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (07)
  • [24] Fibrin-associated EBV-positive Large B-Cell Lymphoma An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation
    Boyer, Daniel F.
    McKelvie, Penelope A.
    de Leval, Laurence
    Edlefsen, Kerstin L.
    Ko, Young-Hyeh
    Aberman, Zachary A.
    Kovach, Alexandra E.
    Masih, Aneal
    Nishino, Ha T.
    Weiss, Lawrence M.
    Meeker, Alan K.
    Nardi, Valentina
    Palisoc, Maryknoll
    Shao, Lina
    Pittaluga, Stefania
    Ferry, Judith A.
    Harris, Nancy Lee
    Sohani, Aliyah R.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (03) : 299 - 312
  • [25] EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management
    Castillo, Jorge J.
    Beltran, Brady E.
    Miranda, Roberto N.
    Young, Ken H.
    Chavez, Julio C.
    Sotomayor, Eduardo M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (05) : 529 - 537
  • [26] EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
    Beltran B.
    Salas R.
    Quĩones P.
    Morales D.
    Hurtado F.
    Cotrina E.
    Riva L.
    Castillo J.
    Infectious Agents and Cancer, 4 (1)
  • [27] EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations
    Courville, Elizabeth L.
    Yohe, Sophia
    Chou, David
    Nardi, Valentina
    Lazaryan, Aleksandr
    Thakral, Beenu
    Nelson, Andrew C.
    Ferry, Judith A.
    Sohani, Aliyah R.
    MODERN PATHOLOGY, 2016, 29 (10) : 1200 - 1211
  • [28] Fibrin-Associated, EBV-Negative Diffuse Large B-Cell Lymphoma Arising in Atrial Myxoma: Expanding the Spectrum of the Entity
    Baugh, Laura
    Brown, Noah
    Song, Joo Y.
    Pandya, Shreyash
    Montoya, Vernon
    Perry, Anamarija M.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2022, 30 (01) : 39 - 45
  • [29] Trophoblast Cell Surface Antigen 2 (Trop2) Is Expressed in Cases of EBV-Positive Diffuse Large B-Cell Lymphoma Emerging from Angioimmunoblastic T-Cell Lymphoma
    Ghandili, Susanne
    Dierlamm, Judith
    Bokemeyer, Carsten
    von Bargen, Clara Marie
    Menz, Anne
    Weidemann, Soeren Alexander
    REPORTS, 2024, 7 (02)
  • [30] Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report
    Hu, Pan
    Ben, Yu
    Liu, Juan
    Zheng, Weicheng
    Yan, Xiyue
    Zhang, Yaping
    Shi, Wenyu
    ONCOTARGETS AND THERAPY, 2021, 14 : 2489 - 2495
12345